UK Signs Deal with GSK and Sanofi for Coronavirus Vaccine

Pharmaceutical giants Sanofi and GlaxoSmithKline (GSK) have agreed to supply 60 million doses of potential Covid-19 vaccine to UK. The two organizations made the announcement on Wednesday.

Sanofi of France and GSK of the United Kingdom have signed a deal regarding the Covid-19 vaccine, BBC reports.

Sanofi is in talks with European Union, France, Italy to ensure availability of the vaccine in global race to stop the pandemic.

Both Sanofi and GSK said in an announcement that they were “committed to making the vaccine available globally”.

Read More: US Hopeful for New Treatment Method for Coronavirus

Roger Connor, president of GSK Vaccines, said, Sanofi hopes to have their vaccine approved by regulatory authorities by the middle of next year.

The UK has inked deals with US pharma giant Pfizer and Germany’s Bioentech to get 90 million doses of vaccine.

The British government has said it will buy 100 million doses of the promising vaccines from Oxford University and AstraZeneca.

This vaccine being developed by AstraZeneca is currently on trial.

Subscribe to Our Latest Newsletter

To Read Our Exclusive Content, Sign up Now.
$5/Monthly, $50/Yearly

NordPass

RECENT POSTS

Google Pixel 8 Series Price and Specs Leaked Ahead of Next Week Launch

On October 4, the Google Pixel 8 series will...

Circular Packaging Systems: From Consumer to Compost and Back

Are you tired of the never-ending cycle of waste...

Can Shubman Gill Break Sachin Tendulkar’s Unbreakable ODI Record?

Shubman Gill is 665 runs short of beating Sachin...

Macbook Air 15 Review: Performance, Design, and User Experience [Updated]

Are you looking for a laptop with powerful performance...

Demystifying Cloud Data Storage: How the Cloud Revolutionizes Data Management?

Are you curious about how the cloud can transform...

ASTROLOGY

LIFESTYLE

BUSINESS

TECHNOLOGY

HEALTH

FEATURED STORIES